1Garland C, Shekelle RB, Barrett-Connor E, et al. (1985) Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet i, 307–309.
2Kampman E, Slattery ML, Caan B, et al. (2000) Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control 11, 459–466.
3Wu K, Willett WC, Fuchs CS, et al. (2002) Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 94, 437–446.
4Shin MH, Holmes MD, Hankinson SE, et al. (2002) Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 94, 1301–1311.
5McCullough ML, Rodriguez C, Diver WR, et al. (2005) Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 14, 2898–2904.
6Giovannucci E, Rimm EB, Wolk A, et al. (1998) Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 58, 442–447.
7Chan JM, Giovannucci E, Andersson SO, et al. (1998) Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes Control 9, 559–566.
8Chan JM, Stampfer MJ, Ma J, et al. (2001) Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr 74, 549–554.
9Kearney J, Giovannucci E, Rimm EB, et al. (1996) Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol 143, 907–917.
10Martinez ME, Giovannucci EL, Colditz GA, et al. (1996) Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst 88, 1375–1382.
11Larsson SC, Bergkvist L & Wolk A (2009) Long-term dietary calcium intake and breast cancer risk in a prospective cohort of women. Am J Clin Nutr 89, 277–282.
12Park SY, Murphy SP, Wilkens LR, et al. (2007) Calcium, vitamin D, and dairy product intake and prostate cancer risk: the Multiethnic Cohort Study. Am J Epidemiol 166, 1259–1269.
13Park Y, Mitrou PN, Kipnis V, et al. (2007) Calcium, dairy foods, and risk of incident and fatal prostate cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol 166, 1270–1279.
14Anderson L, Cotterchio M, Vieth R, et al. (2010) Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women. Am J Clin Nutr 91, 1699–1707.
15Lappe JM, Travers-Gustafson D, Davies KM, et al. (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85, 1586–1591.
16Avenell A, Maclennan GS, Jenkinson DJ, et al. (2012) Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D3 and/or calcium (RECORD Trial). J Clin Endocrinol Metab 97, 614–622.
17Chlebowski RT, Johnson KC, Kooperberg C, et al. (2008) Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100, 1581–1591.
18Wactawski-Wende J, Kotchen JM, Anderson GL, et al. (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354, 684–696.
19Bolland MJ & Reid IR (2008) Calcium supplementation and cancer incidence. Am J Clin Nutr 87, 792–793.
20Bolland MJ, Grey A, Gamble GD, et al. (2011) Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr 94, 1144–1149.
21Bolland MJ, Avenell A, Baron JA, et al. (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341, c3691.
22Reid IR, Ames RW, Evans MC, et al. (1993) Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 328, 460–464.
23Baron JA, Beach M, Mandel JS, et al. (1999) Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 340, 101–107.
24Bonnick S, Broy S, Kaiser F, et al. (2007) Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density. Curr Med Res Opin 23, 1341–1349.
25Grant AM, Avenell A, Campbell MK, et al. (2005) Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365, 1621–1628.
26Reid IR, Mason B, Horne A, et al. (2006) Randomized controlled trial of calcium in healthy older women. Am J Med 119, 777–785.
27Reid IR, Ames R, Mason B, et al. (2008) Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med 168, 2276–2282.
28Bonithon-Kopp C, Kronborg O, Giacosa A, et al. (2000) Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet 356, 1300–1306.
29Chailurkit LO, Saetung S, Thakkinstian A, et al. (2010) Discrepant influence of vitamin D status on parathyroid hormone and bone mass after two years of calcium supplementation. Clin Endocrinol (Oxf) 73, 167–172.
30Riggs BL, O'Fallon WM, Muhs J, et al. (1998) Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res 13, 168–174.
31Peacock M, Liu G, Carey M, et al. (2000) Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab 85, 3011–3019.
32Smith EL, Gilligan C, Smith PE, et al. (1989) Calcium supplementation and bone loss in middle-aged women. Am J Clin Nutr 50, 833–842.
33Elders PJ, Netelenbos JC, Lips P, et al. (1991) Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab 73, 533–540.
34Recker RR, Hinders S, Davies KM, et al. (1996) Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 11, 1961–1966.
35Prince RL, Devine A, Dhaliwal SS, et al. (2006) Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 166, 869–875.
36Dawson-Hughes B, Dallal GE, Krall EA, et al. (1990) A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323, 878–883.
37Baron JA, Beach M, Wallace K, et al. (2005) Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 14, 586–589.
38Schabas R (2008) Artifact in the control group undermines the conclusions of a vitamin D and cancer study. Am J Clin Nutr 87, 792.
39Manson JE, Bassuk SS, Lee IM, et al. (2012) The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 33, 159–171.
40Hofstad B, Almendingen K, Vatn M, et al. (1998) Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion 59, 148–156.
41Majumdar SR, Fletcher RH & Evans AT (1999) How does colorectal cancer present? Symptoms, duration, and clues to location. Am J Gastroenterol 94, 3039–3045.
42Lewis JR, Zhu K & Prince RL (2011) Adverse events from calcium supplementation: relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation. J Bone Miner Res 27, 719–722.
43Sanders JL, Chattopadhyay N, Kifor O, et al. (2001) Ca(2+)-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab 281, E1267–E1274.
44Ritchie CK, Thomas KG, Andrews LR, et al. (1997) Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis. Prostate 30, 183–187.